Allogeneic cell therapy player Century raises $160m in funds to advance pre-clinical pipeline

Allogeneic cell therapy player Century raises $160m in funds to advance pre-clinical pipeline

Source: 
Biopharma Reporter
snippet: 

Century Therapeutics has announced the closing of a US$160m Series C financing round.